859 related articles for article (PubMed ID: 30150039)
21. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
[TBL] [Abstract][Full Text] [Related]
22. Validity of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for pretreatment evaluation of patients with cervical carcinoma: a retrospective pathology-matched study.
Dong Y; Wang X; Wang Y; Liu Y; Zhang J; Qian W; Wu S
Int J Gynecol Cancer; 2014 Nov; 24(9):1642-7. PubMed ID: 25268748
[TBL] [Abstract][Full Text] [Related]
23. False negative rate at
Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
[TBL] [Abstract][Full Text] [Related]
24. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY
J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive CT radiomic model for preoperative prediction of lymph node metastasis in early cervical carcinoma.
Chen J; He B; Dong D; Liu P; Duan H; Li W; Li P; Wang L; Fan H; Wang S; Zhang L; Tian J; Huang Z; Chen C
Br J Radiol; 2020 Apr; 93(1108):20190558. PubMed ID: 31957473
[TBL] [Abstract][Full Text] [Related]
26. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma.
Vural GU; Akkas BE; Demirel BB
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):268-73. PubMed ID: 25018135
[TBL] [Abstract][Full Text] [Related]
27. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
[TBL] [Abstract][Full Text] [Related]
28. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
[TBL] [Abstract][Full Text] [Related]
29. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
31. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
Wright JD; Dehdashti F; Herzog TJ; Mutch DG; Huettner PC; Rader JS; Gibb RK; Powell MA; Gao F; Siegel BA; Grigsby PW
Cancer; 2005 Dec; 104(11):2484-91. PubMed ID: 16270319
[TBL] [Abstract][Full Text] [Related]
32. Ability of
Ou X; Wang J; Zhou R; Zhu S; Pang F; Zhou Y; Tian R; Ma X
Contrast Media Mol Imaging; 2019; 2019():4507694. PubMed ID: 30930700
[No Abstract] [Full Text] [Related]
33. The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
Yilmaz B; Dağ S; Ergul N; Çermik TF
Nucl Med Commun; 2019 Mar; 40(3):219-227. PubMed ID: 30585896
[TBL] [Abstract][Full Text] [Related]
34. The role of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer.
Umesaki N; Tanaka T; Miyama M; Kawabe J; Okamura T; Koyama K; Ochi H; Ogita S
Oncol Rep; 2000; 7(6):1261-4. PubMed ID: 11032926
[TBL] [Abstract][Full Text] [Related]
35. Significant value of
Peng H; Chen L; Tang LL; Li WF; Mao YP; Guo R; Zhang Y; Liu LZ; Tian L; Zhang X; Lin XP; Guo Y; Sun Y; Ma J
Chin J Cancer; 2017 Dec; 36(1):95. PubMed ID: 29258597
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
Nogami Y; Banno K; Irie H; Iida M; Kisu I; Masugi Y; Tanaka K; Tominaga E; Okuda S; Murakami K; Aoki D
Jpn J Clin Oncol; 2015 Jan; 45(1):26-34. PubMed ID: 25368102
[TBL] [Abstract][Full Text] [Related]
37. Radiomics analysis of [
Kudoh T; Haga A; Kudoh K; Takahashi A; Sasaki M; Kudo Y; Ikushima H; Miyamoto Y
Oral Radiol; 2023 Jan; 39(1):41-50. PubMed ID: 35254609
[TBL] [Abstract][Full Text] [Related]
38.
Tsujikawa T; Rahman T; Yamamoto M; Yamada S; Tsuyoshi H; Kiyono Y; Kimura H; Yoshida Y; Okazawa H
Ann Nucl Med; 2017 Nov; 31(9):678-685. PubMed ID: 28815452
[TBL] [Abstract][Full Text] [Related]
39. Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.
Liu S; Li R; Liu Q; Sun D; Yang H; Pan H; Wang L; Song S
Cancer Biomark; 2022; 33(2):249-259. PubMed ID: 35213357
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]